Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The BK (Big Potassium) channel alpha subunit, encoded by the KCNMA1 gene, forms a homotetrameric, large-conductance, voltage and calcium-activated potassium channel. It regulates smooth muscle tone, neuronal excitability, and neurotransmitter release by conducting potassium ions out of the cell upon activation by membrane depolarization and intracellular calcium increase. Dysfunction is implicated in hypertension and neurological disorders, making it a therapeutic target.
Modulation of potassium ion flow, leading to membrane hyperpolarization and reduced cell excitability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Maxi-K Channel Alpha Subunit (BK Channel Alpha Subunit).